US equities
|
SPCX
$166.84
▲+4.96%
NVDA
$236.66
▲+1.16%
MU
$1,063.92
▼-1.02%
TSLA
$377.83
▲+1.95%
MSFT
$525.52
▲+1.54%
SNDK
$1,711.79
▼-0.48%
INTC
$117.10
▼-1.87%
META
$745.91
▲+2.45%
SPCX
$166.84
▲+4.96%
NVDA
$236.66
▲+1.16%
MU
$1,063.92
▼-1.02%
TSLA
$377.83
▲+1.95%
MSFT
$525.52
▲+1.54%
SNDK
$1,711.79
▼-0.48%
INTC
$117.10
▼-1.87%
META
$745.91
▲+2.45%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
ABVC BioPharma, Inc. - Common Stock
(NQ:
ABVC
)
1.000
-0.010 (-0.98%)
Delayed Quote
Updated: 11:35 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ABVC BioPharma, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
ABVC BioPharma Receives $100,000 Milestone Payment From ForSeeCon, Strengthening Vitargus(R) Licensing Deal
August 22, 2025
Via
TheNewswire.com
ABVC BioPharma Receives $100,000 Milestone Payment From ForSeeCon, Strengthening Vitargus(R) Licensing Deal
August 22, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma, Inc. Reports 103% Year-Over-Year Asset Growth and Secures $350K in Post-Quarter Licensing Revenue in Q2 2025
August 14, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma, Inc. Reports 103% Year-Over-Year Asset Growth and Secures $350K in Post-Quarter Licensing Revenue in Q2 2025
August 14, 2025
Via
TheNewswire.com
BioKey Stands as a Strategic U.S. Pharmaceutical Platform Amid Global Tariff Shifts
August 08, 2025
Via
TheNewswire.com
Topics
World Trade
ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma
July 24, 2025
Via
TheNewswire.com
ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
July 18, 2025
Via
TheNewswire.com
Abvc BioPharma Doubles Assets in Q2
↗
August 14, 2025
Via
The Motley Fool
BioKey Stands as a Strategic U.S. Pharmaceutical Platform Amid Global Tariff Shifts
August 08, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
World Trade
ABVC BioPharma Gains Confidence From International Investors to Support Growth Path
August 06, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Gains Confidence From International Investors to Support Growth Path
August 06, 2025
Via
TheNewswire.com
ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
July 10, 2025
Via
TheNewswire.com
OncoX Deepens ABVC Alliance
August 01, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
OncoX Deepens ABVC Alliance
August 01, 2025
Via
TheNewswire.com
Topics
Initial Public Offering
ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma
July 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
July 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
July 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Let's take a look at the stocks that are in motion in today's session.
↗
July 10, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology
June 26, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology
June 26, 2025
Via
TheNewswire.com
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment
June 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment
June 24, 2025
Via
TheNewswire.com
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 06, 2025
Via
Benzinga
ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million
June 06, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million
June 06, 2025
Via
TheNewswire.com
ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value
June 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value
June 03, 2025
Via
TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 21, 2025
Via
Benzinga
ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance
May 14, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Artificial Intelligence
ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance
May 14, 2025
Via
TheNewswire.com
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
